My watch list
my.bionity.com  
Login  

10-04-2012: Catalent Pharma Solutions and BASF have entered into a broad collaboration and Open Alliance to provide solutions to overcome bioavailability challenges of new molecular entities with solubility or permeability challenges.

The companies aim to combine their expertise to provide pharmaceutical customers with a unique range of seamless solutions to address pipeline challenges with a large majority of BCS Class II and IV poorly bioavailable compounds. From feasibility studies across multiple technologies, solid state chemistry, consulting and training, expert formulation services, excipients and optimal dose form development, to scale-up and supply, BASF and Catalent provide a full solution to one of the most important pipeline challenges in the industry – getting better treatments to market faster.

Contact / Request information

Request further information free of charge:

Watchlist

This is where you can add this news to your personal favourites

Facts, background information, dossiers
More about Catalent Pharma Solutions
More about BASF
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE